Cargando…
CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137546/ https://www.ncbi.nlm.nih.gov/pubmed/27435168 http://dx.doi.org/10.1080/21645515.2016.1206677 |
_version_ | 1782471938685272064 |
---|---|
author | Kranz, Lena M. Birtel, Matthias Hilscher, Lina Grunwitz, Christian Petschenka, Jutta Vascotto, Fulvia Vormehr, Mathias Voss, Ralf-Holger Kreiter, Sebastian Diken, Mustafa |
author_facet | Kranz, Lena M. Birtel, Matthias Hilscher, Lina Grunwitz, Christian Petschenka, Jutta Vascotto, Fulvia Vormehr, Mathias Voss, Ralf-Holger Kreiter, Sebastian Diken, Mustafa |
author_sort | Kranz, Lena M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5137546 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-51375462016-12-11 CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany Kranz, Lena M. Birtel, Matthias Hilscher, Lina Grunwitz, Christian Petschenka, Jutta Vascotto, Fulvia Vormehr, Mathias Voss, Ralf-Holger Kreiter, Sebastian Diken, Mustafa Hum Vaccin Immunother Meeting Report Taylor & Francis 2016-07-19 /pmc/articles/PMC5137546/ /pubmed/27435168 http://dx.doi.org/10.1080/21645515.2016.1206677 Text en © 2016 The Author(s). Published with license by Taylor & Francis. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. |
spellingShingle | Meeting Report Kranz, Lena M. Birtel, Matthias Hilscher, Lina Grunwitz, Christian Petschenka, Jutta Vascotto, Fulvia Vormehr, Mathias Voss, Ralf-Holger Kreiter, Sebastian Diken, Mustafa CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany |
title | CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany |
title_full | CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany |
title_fullStr | CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany |
title_full_unstemmed | CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany |
title_short | CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany |
title_sort | cimt 2016: mechanisms of efficacy in cancer immunotherapy — report on the 14th annual meeting of the association for cancer immunotherapy may 10–12 2016, mainz, germany |
topic | Meeting Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137546/ https://www.ncbi.nlm.nih.gov/pubmed/27435168 http://dx.doi.org/10.1080/21645515.2016.1206677 |
work_keys_str_mv | AT kranzlenam cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany AT birtelmatthias cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany AT hilscherlina cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany AT grunwitzchristian cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany AT petschenkajutta cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany AT vascottofulvia cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany AT vormehrmathias cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany AT vossralfholger cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany AT kreitersebastian cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany AT dikenmustafa cimt2016mechanismsofefficacyincancerimmunotherapyreportonthe14thannualmeetingoftheassociationforcancerimmunotherapymay10122016mainzgermany |